← Evidence map

ArticleCancer immunology, immunotherapy : CII2003

Tumor immunotherapy by converting tumor cells to MHC class II-positive, Ii protein-negative phenotype.

Xueqing Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

8 papers cite it

2003

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

this papercites it

Tumor immunotherapy by converting tumor cells to MHC class II-positive, Ii protein-negative phenotype. | OpenQuestion